Century Therapeutics Inc (IPSC)

Nov 28, 2025

What analysts say about Century Therapeutics Inc stockStraddle and Strangle Trades & Double Or Triple Wealth - earlytimes.in

Nov 28, 2025

Nov 25, 2025

Century Therapeutics 'moving with urgency' to develop drug for Type 1 diabetes - The Business Journals

Nov 25, 2025

Nov 25, 2025

Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference - Investing News Network

Nov 25, 2025

Nov 25, 2025

There is no way Century Therapeutics Inc (IPSC) can keep these numbers up - Setenews

Nov 25, 2025

Nov 24, 2025

[Form 4] Century Therapeutics, Inc. Insider Trading Activity - Stock Titan

Nov 24, 2025

Nov 21, 2025

Century Therapeutics Debuts Immune-Evasive Cell Therapy Aiming to Transform Type 1 Diabetes - MSN

Nov 21, 2025

Nov 20, 2025

Century Therapeutics Unveils iPSC Beta Islet Program as Cash Runway Extends Into 2027 - MSN

Nov 20, 2025

Nov 20, 2025

Century Therapeutics Executive Acquires 35,000 Shares - TradingView

Nov 20, 2025

Nov 20, 2025

Chmn Pfeiffenberger Buys 35,000 ($17.3K) Of Century Therapeutics Inc [IPSC] - TradingView

Nov 20, 2025

Nov 20, 2025

Officer Cowan Files To Sell 5,462 Of Century Therapeutics Inc [IPSC] - TradingView

Nov 20, 2025

Nov 20, 2025

Research Analysts Set Expectations for IPSC FY2025 Earnings - Defense World

Nov 20, 2025

Nov 20, 2025

Century Therapeutics Inc. stock momentum explainedMarket Performance Recap & Weekly Stock Performance Updates - newser.com

Nov 20, 2025

Nov 19, 2025

What machine learning models say about Century Therapeutics Inc.2025 Fundamental Recap & Daily Technical Forecast Reports - newser.com

Nov 19, 2025

Nov 19, 2025

Century Therapeutics Executive Sells Shares to Cover Tax Obligations - TradingView

Nov 19, 2025

Nov 19, 2025

Real time pattern detection on Century Therapeutics Inc. stockIPO Watch & Safe Capital Growth Trade Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Leerink Partners Reaffirms “Market Perform” Rating for Century Therapeutics (NASDAQ:IPSC) - Defense World

Nov 19, 2025

Nov 19, 2025

Leerink Partnrs Downgrades Century Therapeutics (NASDAQ:IPSC) to Hold - Defense World

Nov 19, 2025

Nov 18, 2025

Take off with Century Therapeutics Inc (IPSC): Get ready for trading - Setenews

Nov 18, 2025

Nov 17, 2025

What technical signals suggest for Century Therapeutics Inc. stockCPI Data & Accurate Entry and Exit Point Alerts - newser.com

Nov 17, 2025

Nov 17, 2025

How Century Therapeutics Inc. stock compares to industry benchmarksMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com

Nov 17, 2025

Nov 17, 2025

Century Therapeutics Shares Fall After Leerink Partners Downgrade - MarketScreener

Nov 17, 2025

Nov 17, 2025

IPSC Stock Downgraded by Leerink Partners: Price Target Slashed - GuruFocus

Nov 17, 2025

Nov 17, 2025

Leerink Partners Downgrades Century Therapeutics to Market Perform From Outperform, Price Target is $7 - MarketScreener

Nov 17, 2025

Nov 17, 2025

Century Therapeutics stock downgraded by Leerink Partners on lack of catalysts - Investing.com Canada

Nov 17, 2025

Nov 17, 2025

Leerink Partners Downgrades Century Therapeutics to Market Perform From Outperform - MarketScreener

Nov 17, 2025

Nov 16, 2025

What Fibonacci levels say about Century Therapeutics Inc. reboundRisk Management & Free Technical Confirmation Trade Alerts - newser.com

Nov 16, 2025

Nov 15, 2025

Analyzing drawdowns of Century Therapeutics Inc. with statistical toolsQuarterly Market Summary & AI Powered Market Entry Strategies - newser.com

Nov 15, 2025

Nov 15, 2025

Century Therapeutics Inc. stock trend outlook and recovery pathWeekly Trade Recap & High Accuracy Investment Entry Signals - newser.com

Nov 15, 2025

Nov 15, 2025

Published on: 2025-11-15 03:30:02 - newser.com

Nov 15, 2025

Nov 14, 2025

Can volume confirm reversal in Century Therapeutics Inc.2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com

Nov 14, 2025

Nov 14, 2025

Century Therapeutics unveils β islet program for type 1 diabetes - BioWorld MedTech

Nov 14, 2025

Nov 14, 2025

Century Therapeutics Reports Positive Q3 2025 Earnings - TipRanks

Nov 14, 2025

Nov 13, 2025

Century Therapeutics Shrinks Costs But Net Loss Widens - Finimize

Nov 13, 2025

Nov 13, 2025

Century Therapeutics Inc. stock trendline breakdownPortfolio Growth Summary & Daily Technical Stock Forecast Reports - newser.com

Nov 13, 2025

Nov 13, 2025

Century Therapeutics unveils T1D therapy program with immune evasion tech By Investing.com - Investing.com Nigeria

Nov 13, 2025

Nov 13, 2025

Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - Investing News Network

Nov 13, 2025

Nov 13, 2025

[8-K] Century Therapeutics, Inc. Reports Material Event | IPSC SEC FilingForm 8-K - Stock Titan

Nov 13, 2025

Nov 13, 2025

Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes - Investing News Network

Nov 13, 2025

Nov 13, 2025

Century Therapeutics Q3 net loss widens, despite lower costs - MarketScreener

Nov 13, 2025

Nov 13, 2025

Century Therapeutics, Inc. SEC 10-Q Report - TradingView

Nov 13, 2025

Nov 13, 2025

Century Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 13, 2025

Nov 13, 2025

[10-Q] Century Therapeutics, Inc. Quarterly Earnings Report | IPSC SEC FilingForm 10-Q - Stock Titan

Nov 13, 2025

Nov 13, 2025

Century Therapeutics unveils T1D therapy program with immune evasion tech - Investing.com

Nov 13, 2025

Nov 13, 2025

Century Therapeutics Announces Breakthrough Allo-Evasion™ 5.0 iPSC Beta Islet Therapy for Type 1 Diabetes with Plans for IND Submission by 2026 - Quiver Quantitative

Nov 13, 2025